Recommendations of the National Heart, Lung, and Blood Institute working group on future direction in cardiac surgery

Circulation

Volumn 111, Issue 22, 2005, Pages 3007-3013

  Baumgartner, William A ^a,b   Burrows, Stephanie ^a   Del Nido, Pedro J ^a   Gardner, Timothy J ^a   Goldberg, Suzanne ^a   Gorman, Robert C ^a   Letsou, George V ^a   Mascette, Alice ^a   Michler, Robert E ^a   Puskas, John D ^a   Rose, Eric A ^a   Rosengart, Todd K ^a   Sellke, Frank W ^a   Shumway, Sara J ^a   Wilke, Norbert ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Heart diseases; Research; Surgery

Indexed keywords

BIOTECHNOLOGY; CARDIOVASCULAR SURGERY; CELL BASED GENE THERAPY; CLINICAL RESEARCH; HEART MUSCLE REVASCULARIZATION; HEART PRESERVATION; HEART SURGERY; OFF PUMP CORONARY SURGERY; PRIORITY JOURNAL; RESEARCH; REVASCULARIZATION; REVIEW; SURGICAL APPROACH; TREATMENT PLANNING;

CARDIAC SURGICAL PROCEDURES; CELL TRANSPLANTATION; DIAGNOSTIC IMAGING; FORECASTING; HEART DISEASES; HUMANS; POSTOPERATIVE COMPLICATIONS; RESEARCH;

EID: 20444507640     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.530154     Document Type: Review

References (19)

1. Mack MJ, Brown PP, Kugelmass AD, Battaglia SL, Tarkington LG, Simon AW, Culler SD, Becker ER. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures. Ann Thorac Surg. 2004;77:761-768.
2. Cleveland JC, Shroyer AL, Chen AY, Peterson E, Grover FL. Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. Ann Thorac Surg. 2001;72:1282-1289.
3. Nathoe HM, van Dijk D, Jansen EW, Suyker WJ, Diephuis JC, van Boven WJ, de la Riviere AB, Borst C, Kalkman CJ, Grobbee DE, Buskens E, de Jaegere PP; Octopus Study Group. A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients. N Engl J Med. 2004;348:394-402.
4. Gorman RC, Gorman JH III, Edmunds LH Jr. Ischemic mitral regurgitation in cardiac surgery in the adult. In: Cohn LH, Edmunds LH Jr, eds. Cardiac Surgery in the Adult. New York, NY: McGraw-Hill; 2003: 1751-1770.
5. Gillinov AM, Wierup PN, Blackstone EH, Bishay ES, Cosgrove DM, White J, Lytle BW, McCarthy PM. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg. 2001;122: 1125-1141.
6. Diodato MD, Moon MR, Pasque MK, Barner HB, Moazami N, Lawton JS, Bailey MS, Guthrie TJ, Meyers BF, Damiano RJ Jr. Repair of ischemic mitral regurgitation does not increase mortality or improve long-term survival in patients undergoing coronary artery revascularization: a propensity analysis. Ann Thorac Surg. 2004;78:794-799.
7. Guy TS, Moainie SL, Gorman JH III, Jackson BM, Plappert T, Enomoto Y, St. John-Sutton MG, Edmunds LH, Gorman RC. Prevention of ischemic mitral regurgitation does not influence the outcome of remodeling after posterolateral myocardial infarction. J Am Coll Cardiol. 2004;43: 377-383.
8. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley C, Manning WJ, Sellke FW, Simons M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 1994;94:623-630.
9. Schalch P, Rahman GF, Patejunas G, Goldschmidt RA, Carbray J, Retuerto MA, Kim D, Esser K, Crystal RG, Rosengart TK. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state. J Thorac Cardiovasc Surg. 2004;127:535-540.
10. Simons MS, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double blind, randomized, controlled clinical trial. Circulation. 2002;105:788-793.
11. Ruel M, Wu GF, Khan TA, Voisine P, Bianchi C, Li J, Li J, Laham RJ, Sellke FW. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a swine endothelial dysfunction model. Circulation. 2003;108(suppl 1)II-335-II-340.
12. Metais C, Li JY, Li J, Simons M, Sellke FW. Effect of coronary artery disease on expression and microvascular response to VEGF. Am J Physiol (Heart Circul Physiol). 1998;275:H1411-H1418.
13. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001;33:907-921.
14. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
15. McConnell PI, Michler RE. Clinical trials in the surgical management of congestive heart failure: surgical ventricular restoration, autologous skeletal myoblast and stem cell cardiomyoplasty. Cardiology. 2004;101: 48-60.
16. Arai AE, Kwong RY. Detecting acute coronary syndrome in the emergency department using cardiac magnetic resonance imaging. Cardiovasc Rev Rep. 2004;25:149-154.
17. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
18. Becker CR. Assessment of coronary arteries with CT. Radiol Clin North Am. 2002;40:773-782, vi.
19. Rickers C, Jerosch-Herold M, Hu X, Murthy N, Wang X, Kong H, Seethamraju RT, Weil J, Wilke NM. Magnetic resonance image-guided transcatheter closure of atrial septal defects. Circulation. 2003;107: 132-138.